ArticleFrontiers in oncology2023

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.

Roshan Asrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.